AbstractObjectives
Orostachys japonicas (O. japonicus) has been known for its anti-tumor effect. In the present study, it was investigated whether O. japonicus EtOH extracts could induce apoptosis and autophagy which are part of the main mechanism related to anti-tumor effect in THP-1 cells.
MethodsCells were treated with various concentrations of O. japonicus EtOH extracts (0–300μg/ml) for 24, 48, and 72h. Cell viability was evaluated by MTS/PMS assay and apoptosis rate was examined by flow cytometry and ELISA assay. The mRNA expression of apoptosis-related genes (Bcl-2, Mcl-1, Survivin, Bax) and autophagy-related gene (mTOR) was evaluated using real-time PCR. The protein expression of Caspase-3, Akt, LC3II, Beclin-1, Atg5, NF-κB, p38, ERK was evaluated using western blot analysis.
Results
O. japonicus EtOH extracts inhibited cell proliferation and apoptosis rate was increased in both flow cytometry and ELISA assay. Bcl-2, Mcl-1, Survivin (anti-apoptosis factors) mRNA expressions were decreased and Bax (pro-apoptosis factor) mRNA level was increased. mTOR mRNA expressions was decreased and LC3II protein expressions was increased. Activation of NF-κB was decreased and phosphorylation of p38 was increased.
참고문헌1. De Kouchkovsky, I, & Abdul-Hay, M. Acute myeloid leukemia: a comprehensive review and 2016 update. Blood cancer journal, (2016). 6(7), e441.
2. Park, EH, Lee, H, Won, YJ, Ju, HY, Oh, CM, & Ingabire, C, et al. Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012. Blood research, (2015). 50(4), 204-217.
3. Lowenberg, B, Downing, JR, & Burnett, A. Acute myeloid leukemia. New England Journal of Medicine, (1999). 341(14), 1051-1062.
4. Shah, A, Andersson, TML, Rachet, B, Björkholm, M, & Lambert, PC. Survival and cure of acute myeloid leukaemia in England, 1971–2006: a population-based study. British journal of haematology, (2013). 162(4), 509-516.
5. Meyers, J, Yu, Y, Kaye, JA, & Davis, KL. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs. Applied health economics and health policy, (2013). 11(3), 275-286.
6. Ahn DG. Illustrated guide to clinical medicinal herbs. Seoul. Hyun-am-sa;(2012). p. 697-698.
7. Ryu, DS, Baek, GO, Kim, EY, Kim, KH, & Lee, DS. Effects of polysaccharides derived from Orostachys Japonicus on induction of cell cycle arrest and apoptotic cell death in human colon cancer cells. BMB reports, (2010). 43(11), 750-755.
8. Shin, DY, Lee, WS, Jung, JH, Hong, SH, Park, C, & Kim, HJ, et al. Flavonoids from Orostachys japonicus A. Berger inhibit the invasion of LnCaP prostate carcinoma cells by inactivating Akt and modulating tight junctions. International journal of molecular sciences, (2013). 14(9), 18407-18420.
9. Ryu, DS, Lee, HS, Lee, GS, & Lee, DS. Effects of the ethylacetate extract of Orostachys japonicus on induction of apoptosis through the p53-mediated signaling pathway in human gastric cancer cells. Biological and Pharmaceutical Bulletin, (2012). 35(5), 660-665.
10. Kim, YI, Park, SW, Choi, IH, Lee, JH, Woo, HJ, & Kim, Y. Effect of Orostachys japonicus on cell growth and apoptosis in human hepatic stellate cell line LX2. The American journal of Chinese medicine, (2011). 39(03), 601-613.
11. Koppula, S, Yum, MJ, Kim, JS, Shin, GM, Chae, YJ, & Yoon, T, et al. Anti-fibrotic effects of Orostachys japonicus A. Berger (Crassulaceae) on hepatic stellate cells and thioacetamide-induced fibrosis in rats. Nutrition research and practice, (2017). 11(6), 470-478.
12. Lee, HS, Ryu, DS, Lee, GS, & Lee, DS. Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: suppression of NF-κB activation and MAPK signaling. Journal of ethnopharmacology, (2012). 140(2), 271-276.
13. Lee, HS, Lee, GS, Kim, SH, Kim, HK, Suk, DH, & Lee, DS. Anti-oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicus in LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway. BMB reports, (2014). 47(2), 98.
14. Gerl, R, & Vaux, DL. Apoptosis in the development and treatment of cancer. Carcinogenesis, (2005). 26(2), 263-270.
15. Mathew, R, Karantza-Wadsworth, V, & White, E. Role of autophagy in cancer. Nature Reviews Cancer, (2007). 7(12), 961.
16. Choi, ES, & Lee, JH. Orostachys japonicus DW and EtOH extracts Induce Apoptosis in Cholangiocarcinoma Cell Line SNU-1079. Journal of Korean Medicine, (2015). 36(4), 19-34.
17. Korean traditional herbal medicine standard book. Korea national legal information center;[cited 2018 December 10]. Available from: http://www.law/go.kr/admRulSc.do?tabMenuId=tab107
18. Sill, H, Olipitz, W, Zebisch, A, Schulz, E, & Wölfler, A. Therapy-related myeloid neoplasms: pathobiology and clinical characteristics. British journal of pharmacology, (2011). 162(4), 792-805.
19. Döhner, H, Estey, EH, Amadori, S, Appelbaum, FR, Büchner, T, & Burnett, AK, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood, (2010). 115(3), 453-474.
20. Vardiman, JW, Thiele, J, Arber, DA, Brunning, RD, Borowitz, MJ, & Porwit, A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood, (2009). 114(5), 937-951.
21. Löwenberg, B, Zittoun, R, Kerkhofs, H, Jehn, U, Abels, J, & Debusscher, L, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. Journal of Clinical Oncology, (1989). 7(9), 1268-1274.
22. Cho, CS, & Cho, JG. A literature review of Orostachys japonicus. Collection of dissertations from Korean Medicine Laboratory, (1994). 2(2), 83-98.
23. Lee, GS, Lee, HS, Kim, SH, Suk, DH, Ryu, DS, & Lee, DS. Anti-cancer activity of the ethylacetate fraction from Orostachys japonicus for modulation of the signaling pathway in HepG2 human hepatoma cells. Food Science and Biotechnology, (2014). 23(1), 269-275.
24. Vivanco, I, & Sawyers, CL. The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nature Reviews Cancer, (2002). 2(7), 489.
25. Shin, DY, Lee, WS, Jung, JH, Hong, SH, Park, C, & Kim, HJ, et al. Flavonoids from Orostachys japonicus A. Berger inhibit the invasion of LnCaP prostate carcinoma cells by inactivating Akt and modulating tight junctions. International journal of molecular sciences, (2013). 14(9), 18407-18420.
26. Jung, CH, Ro, SH, Cao, J, Otto, NM, & Kim, DH. mTOR regulation of autophagy. FEBS letters, (2010). 584(7), 1287-1295.
27. Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Autophagosome and Phagosome. Humana press;(2008). p. 77-88.
28. Kang, R, Zeh, H, Lotze, M, & Tang, D. The Beclin 1 network regulates autophagy and apoptosis. Cell death and differentiation, (2011). 18(4), 571.
29. Codogno, P, & Meijer, AJ. Atg5: more than an autophagy factor. Nature cell biology, (2006). 8(10), 1045.
30. Kim, A, Yim, NH, & Ma, JY. Samsoeum, a traditional herbal medicine, elicits apoptotic and autophagic cell death by inhibiting Akt/mTOR and activating the JNK pathway in cancer cells. BMC complementary and alternative medicine, (2013). 13(1), 233.
31. Reed, JC. Apoptosis-targeted therapies for cancer. Cancer cell, (2003). 3(1), 17-22.
32. Murphy, LO, & Blenis, J. MAPK signal specificity: the right place at the right time. Trends in biochemical sciences, (2006). 31(5), 268-275.
|
|